Medical Therapy with Versus Without Revascularization in Stable Patients with Moderate and Severe Ischemia the Case for Community Equipoise

Journal of the American College of Cardiology

Volumn 67, Issue 1, 2016, Pages 81-99

  Stone, Gregg W ^a   Hochman, Judith S ^b   Williams, David O ^c   Boden, William E ^d   Ferguson, T Bruce ^e   Harrington, Robert A ^f   Maron, David J ^f  

^a NewYork Presbyterian Hospital   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ALBANY MEDICAL CENTER   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

coronary artery bypass; coronary artery disease; guideline directed medical therapy; Key Words angina pectoris; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOVASCULAR AGENT;

BARE METAL STENT; CARDIOVASCULAR MORTALITY; CLINICAL DECISION MAKING; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ELUTING STENT; FRACTIONAL FLOW RESERVE; GUIDELINE DIRECTED MEDICAL THERAPY; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; ISCHEMIA; ISCHEMIC HEART DISEASE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT PREFERENCE; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STABLE ISCHEMIC HEART DISEASE; SURVIVAL; SURVIVAL RATE; SYSTEMATIC REVIEW (TOPIC); COMPARATIVE STUDY; MORTALITY; MYOCARDIAL ISCHEMIA; STENT;

CARDIOVASCULAR AGENTS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; QUALITY OF LIFE; STENTS;

EID: 84952919122     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.09.056     Document Type: Review

References (88)

1. S.C. Smith Jr.; E.J. Benjamin, R.O. Bonow, and et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation J Am Coll Cardiol 58 2011 2432 2446
2. M.F. Piepoli, U. Corrà, W. Benzer, and et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation: a position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation Eur J Cardiovasc Prev Rehabil 17 2010 1 17
3. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
4. S.R. Mehta, C.P. Cannon, K.A. Fox, and et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials JAMA 293 2005 2908 2917
5. K.A. Fox, T.C. Clayton, P. Damman, and et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data J Am Coll Cardiol 55 2010 2435 2445
6. D. Mozaffarian, E.J. Benjamin, A.S. Go, and et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association Circulation 131 2015 e29 e322
7. S. Yusuf, D. Zucker, P. Peduzzi, and et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 1994 563 570
8. W.E. Boden, R.A. O'Rourke, K.K. Teo, et al. for the COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
9. BARI 2D Study Group A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
10. S.D. Fihn, J.M. Gardin, J. Abrams, and et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 60 2012 e44 e164
11. S.D. Fihn, J.C. Blankenship, K.P. Alexander, and et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 64 2014 1929 1949
12. G. Montalescot, U. Sechtem, S. Achenbach, and et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology Eur Heart J 34 2013 2949 3003
13. S. Windecker, P. Kolh, F. Alfonso, and et al. 2014 ESC/EACTS guidelines on myocardial revascularization Eur Heart J 35 2014 2541 2619
14. M.R. Patel, G.J. Dehmer, J.W. Hirshfeld, and et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography J Am Coll Cardiol 59 2012 857 881
15. S. Ellis, E. Alderman, K. Cain, and et al. Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS Registry study J Am Coll Cardiol 11 1988 908 916
16. S. Garcia, Y. Sandoval, H. Roukoz, and et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies J Am Coll Cardiol 62 2013 1421 1431
17. S.J. Head, M.J. Mack, D.R. Holmes Jr.; and et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data Eur J Cardiothorac Surg 41 2012 535 541
18. H.C. Wijeysundera, M.C. Bennell, F. Qiu, and et al. Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study J Gen Intern Med 29 2014 1031 1039
19. J.K. Min, D.S. Berman, A. Dunning, and et al. All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry) Eur Heart J 33 2012 3088 3097
20. E.L. Hannan, Z. Samadashvili, K. Cozzens, and et al. Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York Circulation 125 2012 1870 1879
21. P.A.L. Tonino, W.F. Fearon, B. De Bruyne, and et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study: fractional flow reserve versus angiography in multivessel evaluation J Am Coll Cardiol 55 2010 2816 2821
22. S.J. Park, S.J. Kang, J.M. Ahn, and et al. Visual-functional mismatch between coronary angiography and fractional flow reserve J Am Coll Cardiol Intv 5 2012 1029 1036
23. G. Vanzetto, O. Ormezzano, D. Fagret, and et al. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up Circulation 100 1999 1521 1527
24. D. Pavin, J. Delonca, M. Siegenthaler, and et al. Long-term (10 years) prognostic value of a normal thallium-201 myocardial exercise scintigraphy in patients with coronary artery disease documented by angiography Eur Heart J 18 1997 69 77
25. S.M. Chang, F. Nabi, J. Xu, and et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk J Am Coll Cardiol 54 2009 1872 1882
26. R. Hachamovitch, S.W. Hayes, J.D. Friedman, and et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2003 2900 2907
27. L.J. Shaw, D.S. Berman, D.J. Maron, et al. for the COURAGE Investigators Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
28. S. Dorbala, M.F. Di Carli, R.S. Beanlands, and et al. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry J Am Coll Cardiol 61 2013 176 184
29. L. Cortigiani, L. Borelli, M. Raciti, and et al. Prediction of mortality by stress echocardiography in 2835 diabetic and 11 305 nondiabetic patients Circ Cardiovasc Imaging 8 2015 e002757
30. N.P. Johnson, G.G. Tóth, D. Lai, and et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes J Am Coll Cardiol 64 2014 1641 1654
31. R. Hachamovitch, A. Rozanski, L.J. Shaw, and et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy Eur Heart J 32 2011 1012 1024
32. R. Hachamovitch, X. Kang, A.M. Amanullah, and et al. Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly Circulation 120 2009 2197 2206
33. P. Sorajja, P. Chareonthaitawee, N. Rajagopalan, and et al. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting Circulation 112 2005 I311 I316
34. W. Hueb, N. Lopes, B.J. Gersh, and et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 122 2010 949 957
35. W.S. Weintraub, J.A. Spertus, P. Kolm, et al. for the COURAGE Trial Research Group Effect of PCI on quality of life in patients with stable coronary disease N Engl J Med 359 2008 677 687
36. G.R. Dagenais, J. Lu, D.P. Faxon, et al. for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease Circulation 123 2011 1492 1500
37. M.M. Brooks, S.C. Chung, T. Helmy, et al. for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Circulation 122 2010 1690 1699
38. S. Pursnani, F. Korley, R. Gopaul, and et al. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials Circ Cardiovasc Interv 5 2012 476 490
39. S. Bangalore, B. Toklu, N. Amoroso, and et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis BMJ 347 2013 f6625
40. S. Thomas, R. Gokhale, W.E. Boden, and et al. A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris Can J Cardiol 29 2013 472 482
41. A. Schömig, J. Mehilli, A. de Waha, and et al. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease J Am Coll Cardiol 52 2008 894 904
42. A. Jeremias, S. Kaul, T.K. Rosengart, and et al. The impact of revascularization on mortality in patients with nonacute coronary artery disease Am J Med 122 2009 152 161
43. M.J. Zellweger, C. Kaiser, H.P. Brunner-La Rocca, et al. for the BASKET Investigators Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation J Nucl Med 49 2008 550 556
44. A.J. Kirtane, A. Gupta, S. Iyengar, and et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies Circulation 119 2009 3198 3206
45. M. Valgimigli, M. Sabaté, C. Kaiser, and et al. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis BMJ 349 2014 g6427
46. T. Palmerini, G. Biondi-Zoccai, D. Della Riva, and et al. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis J Am Coll Cardiol 63 2014 299 307
47. S. Windecker, S. Stortecky, G.G. Stefanini, and et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis BMJ 348 2014 g3859
48. L.J. Shaw, W.S. Weintraub, D.J. Maron, and et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention Am Heart J 164 2012 243 250
49. G.J. Bech, B. De Bruyne, N.H. Pijls, and et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial Circulation 103 2001 2928 2934
50. P.A. Tonino, B. De Bruyne, N.H. Pijls, et al. for the FAME Study Investigators Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
51. N.H. Pijls, W.F. Fearon, P.A. Tonino, et al. for the FAME Study Investigators Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study J Am Coll Cardiol 56 2010 177 184
52. B. De Bruyne, N.H. Pijls, B. Kalesan, et al. for the FAME 2 Trial Investigators Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease N Engl J Med 367 2012 991 1001
53. S. Bangalore, S. Pursnani, S. Kumar, and et al. Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease Circulation 127 2013 769 781
54. I.D. Moussa, L.W. Klein, B. Shah, and et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI) J Am Coll Cardiol 62 2013 1563 1570
55. P. Erne, A.W. Schoenenberger, D. Burckhardt, and et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial JAMA 297 2007 1985 1991
56. H. Gada, A.J. Kirtane, D.J. Kereiakes, and et al. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia Am J Cardiol 115 2015 1194 1199
57. J. Iqbal, Y.J. Zhang, D.R. Holmes, and et al. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Circulation 131 2015 1269 1277
58. R. Hutchins, A.J. Viera, S.L. Sheridan, and et al. Quantifying the utility of taking pills for cardiovascular prevention Circ Cardiovasc Qual Outcomes 8 2015 155 163
59. M. Fontana, P. Asaria, M. Moraldo, and et al. Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility Circulation 129 2014 2539 2546
60. S.H. Naderi, J.P. Bestwick, and D.S. Wald Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients Am J Med 125 2012 882 887.e1
61. M.N. Walsh, A.A. Bove, R.R. Cross, and et al. ACCF 2012 health policy statement on patient-centered care in cardiovascular medicine: a report of the American College of Cardiology Foundation Clinical Quality Committee J Am Coll Cardiol 59 2012 2125 2143
62. C. Kocas, O. Abaci, V. Oktay, and et al. Percutaneous coronary intervention vs. optimal medical therapy - the other side of the coin: medication adherence J Clin Pharm Ther 38 2013 476 479
63. J.A. Spertus, R. Kettelkamp, C. Vance, and et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2006 2803 2809
64. V. Bittner, M. Bertolet, R.B. Felix, et al. BARI 2D Study Group Comprehensive cardiovascular risk factor control improves survival: the BARI 2D trial J Am Coll Cardiol 66 2015 765 773
65. G.B. Mancini, P.M. Hartigan, L.J. Shaw, and et al. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia J Am Coll Cardiol Intv 7 2014 195 201
66. L.J. Shaw, M.D. Cerqueira, M.M. Brooks, and et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial J Nucl Cardiol 19 2012 658 669
67. N. Aldweib, K. Negishi, R. Hachamovitch, and et al. Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization J Am Coll Cardiol 61 2013 1616 1623
68. J.A. Panza, T.A. Holly, F.M. Asch, and et al. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction J Am Coll Cardiol 61 2013 1860 1870
69. P.G. Steg, N. Greenlaw, M. Tendera, et al. for the Prospective Observational Longitudinal Registry of Patients With Stable Coronary Artery Disease (CLARIFY) Investigators Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry JAMA Intern Med 174 2014 1651 1659
70. D.G. Katritsis, and J.P. Ioannidis Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis Circulation 111 2005 2906 2912
71. H.C. Wijeysundera, and J.T. Ko Does percutaneous coronary intervention reduce mortality in patients with stable chronic angina: are we talking about apples and oranges? Circ Cardiovasc Qual Outcomes 2 2009 123 126
72. T.A. Trikalinos, A.A. Alsheikh-Ali, A. Tatsioni, and et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis Lancet 373 2009 911 918
73. K. Stergiopoulos, W.E. Boden, P. Hartigan, and et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials JAMA Intern Med 174 2014 232 240
74. W. Hueb, P.R. Soares, B.J. Gersh, and et al. The Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease one-year results J Am Coll Cardiol 43 2004 1743 1751
75. L. Mauri, D.J. Kereiakes, R.W. Yeh, et al. for the DAPT Study Investigators Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents N Engl J Med 371 2014 2155 2166
76. M.P. Bonaca, D.L. Bhatt, M. Cohen, et al. for the PEGASUS-TIMI 54 Steering Committee and Investigators Long-term use of ticagrelor in patients with prior myocardial infarction N Engl J Med 372 2015 1791 1800
77. W.S. Weintraub, W.E. Boden, Z. Zhang, et al. for the Department of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study Coordinators Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients Circ Cardiovasc Qual Outcomes 1 2008 12 20
78. M.A. Hlatky, D.B. Boothroyd, K.A. Melsop, et al. for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Circulation 120 2009 2550 2558
79. W.F. Fearon, D. Shilane, N.H. Pijls, et al. for the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 2 (FAME-2) Investigators Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve Circulation 128 2013 1335 1340
80. M.B. Rothberg, S.K. Sivalingam, J. Ashraf, and et al. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease Ann Intern Med 153 2010 307 313
81. M.B. Rothberg, S.K. Sivalingam, R. Kleppel, and et al. Informed decision making for percutaneous coronary intervention for stable coronary disease JAMA Intern Med 175 2015 1199 1206
82. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
83. G.W. Stone, A. Maehara, A.J. Lansky, et al. for the PROSPECT Investigators A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
84. T. Doenst, J.G. Cleland, J.L. Rouleau, et al. for the STICH Investigators Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease Circ Heart Fail 6 2013 443 450
85. B. Freedman Equipoise and the ethics of clinical research N Engl J Med 317 1987 141 145
86. R. Hachamovitch, B. Nutter, M.A. Hlatky, and et al. Patient management after noninvasive cardiac imaging results from SPARC (Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in Coronary Artery Disease) J Am Coll Cardiol 59 2012 462 474
87. L.J. Shaw, R. Hachamovitch, D.S. Berman, et al. for the Economics of Noninvasive Diagnosis (END) Multicenter Study Group The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia J Am Coll Cardiol 33 1999 661 669
88. D.J. Maron, G.W. Stone, D.S. Berman, and et al. Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists Am Heart J 162 2011 1034 1043